One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis

Novartis’ drug discovery crew inside the NIBR campus in Cambridge, MA is putting $30 million on the table to get a new TCR immuno-oncology program kicked off with one of the recent startups to debut in the field — serious money for what they believe can offer an effective approach to tackling solid tumors.